Literature DB >> 18547804

Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length.

Shuichi Mori1, Shinya Miyake, Takayoshi Kobe, Takaaki Nakaya, Stephen D Fuller, Nobuo Kato, Kunihiro Kaihatsu.   

Abstract

A series of fatty acid monoester derivatives of (-)-epigallocatechin-3-O-gallate (EGCG) were prepared by one-pot lipase-catalyzed transesterification. The introduction of long alkyl chains enhanced anti-influenza A/PR8/34 (H1N1) virus activity 24-fold relative to native EGCG.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547804     DOI: 10.1016/j.bmcl.2008.02.020

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

Review 1.  Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009 - present).

Authors:  Kristin Landis-Piwowar; Di Chen; Robert Foldes; Tak-Hang Chan; Qing Ping Dou
Journal:  Expert Opin Ther Pat       Date:  2012-12-12       Impact factor: 6.674

2.  Epigallocatechin-3-Gallate (EGCG) Inhibits SARS-CoV-2 Infection in Primate Epithelial Cells: (A Short Communication).

Authors:  Brett L Hurst; Douglas Dickinson; Stephen Hsu
Journal:  Microbiol Infect Dis       Date:  2021

3.  Effects of Epigallocatechin-3-Gallate-Palmitate (EC16) on In Vitro Norovirus Infection.

Authors:  Jiarong Zhong; Douglas Dickinson; Stephen Hsu
Journal:  Microbiol Infect Dis       Date:  2021

Review 4.  Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea.

Authors:  J Steinmann; J Buer; T Pietschmann; E Steinmann
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

5.  Inhibition of herpes simplex virus type 1 with the modified green tea polyphenol palmitoyl-epigallocatechin gallate.

Authors:  Aline de Oliveira; Sandra D Adams; Lee H Lee; Sean R Murray; Stephen D Hsu; Jeffrey R Hammond; Douglas Dickinson; Ping Chen; Tin-Chun Chu
Journal:  Food Chem Toxicol       Date:  2012-11-23       Impact factor: 6.023

6.  Antibacterial and antifungal activities of new acylated derivatives of epigallocatechin gallate.

Authors:  Yoshimi Matsumoto; Kunihiro Kaihatsu; Kunihiko Nishino; Miho Ogawa; Nobuo Kato; Akihito Yamaguchi
Journal:  Front Microbiol       Date:  2012-02-16       Impact factor: 5.640

7.  In vitro evaluation of the antiviral activity of the synthetic epigallocatechin gallate analog-epigallocatechin gallate (EGCG) palmitate against porcine reproductive and respiratory syndrome virus.

Authors:  Chunjian Zhao; Shuaihua Liu; Chunying Li; Lei Yang; Yuangang Zu
Journal:  Viruses       Date:  2014-02-21       Impact factor: 5.048

Review 8.  Progress of small molecular inhibitors in the development of anti-influenza virus agents.

Authors:  Xiaoai Wu; Xiuli Wu; Qizheng Sun; Chunhui Zhang; Shengyong Yang; Lin Li; Zhiyun Jia
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

9.  Broad and potent anti-influenza virus spectrum of epigallocatechin-3-O-gallate-monopalmitate.

Authors:  Kunihiro Kaihatsu; Shuichi Mori; Hiroyo Matsumura; Tomo Daidoji; Chiharu Kawakami; Hideshi Kurata; Takaaki Nakaya; Nobuo Kato
Journal:  J Mol Genet Med       Date:  2009-12-16

10.  Anti-influenza (H1N1) potential of leaf and stem bark extracts of selected medicinal plants of South India.

Authors:  Gansukh Enkhtaivan; K M Maria John; Muniappan Ayyanar; Thangavel Sekar; Ki-Joun Jin; Doo Hwan Kim
Journal:  Saudi J Biol Sci       Date:  2015-01-20       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.